HHV HERPES VIRUSES Enveloped dsDNA viruses Similar morphologically but differ clinically and biologically Three groups 1ALPHAHRPES VIRUSES HSV 1 HSV2 AND VZV 2 BETAHERPESVIRUSES ID: 784776
Download The PPT/PDF document "Human herpes virus infections" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Human herpes virus infections
HHV
Slide2HERPES VIRUSES:
Enveloped ,dsDNA viruses. Similar morphologically but differ clinically and biologically. Three groups:
1-ALPHA-HRPES VIRUSES
(
HSV
-1,
HSV-2,
AND
VZV
).
2-
BETA-HERPESVIRUSES
(
CMV
,
HUMAN HERPESVIRUSES(HHV)-6
AND
HHV-7,SIMIAN HERPES B
).
3-
GAMMA-HERPESVIRUSES
(
EBV
AND
HHV-8)
.
Slide3There are
eight human herpes virus
, they are capable of establishing life long
latency
after acute infections, and are also capable for
oncogenesis and reactivation
under certain conditions, these are DNA viruses and divided into subgroups according to their site of latency and their infectious manifestations.HHV are acquired by direct contact with clinically active infected person or through asymptomatic shedding of virus, for many HHV infected saliva is a common source of infection, sexual contact, intrauterine infection and acquiring the infection at time of delivery, blood transfusion ,and transmission at time of transplantation are modes of acquisition depending on HHV type..
Slide4Airborne infection occurred only with VZV
,humoral immunity is required to protect against primary infection but after infection is established it does not control its spread. The cell mediated immune system is responsible for controlling spread,transmission,and severity of HHV infections. Infection prevention relies on screening, safe sexual practices, and infection control measures. Vaccines exist only for VZV.Effective antiviral medications are available for treatment and reducing of reactivation of some of the HHVs.Immunoglobuloin preparation for VZV and CMV are indicated under certain circumstances in immunocompromised persons.
Slide5Although they are closely related and cause similar diseases, herpes simplex viruses 1 and 2 (HSV-1 and
HSV-2) are genetically and serologically distinct. HSV-1 infection occurs earlier in life, with nearly 90% of
adults worldwide having detectable antibodies by age 40 years. HSV-2 is less prevalent, ranging from 20%
to 60% depending on number of sexual partners, sex, and geographic location.
Numerous infection syndromes are caused by HSV, depending on the virus type, host age, immune status,
and anatomic site involved.
HSV-1
most frequently manifests as gingivostomatitis and
pharyngitis
HSV-2
is a common cause of genital ulcer disease worldwide
Primary
genital infection during pregnancy may be transmitted to the fetus and lead to spontaneous abortion.
Although recurrent infection occurs more often during pregnancy, neonatal outcome is usually unaffected in
seropositive women.
Slide6HSV-1 and HSV-2 may cause other cutaneous manifestations, including infection of the finger (herpetic
whitlow) or skin (herpes gladiatorum
).
Involvement of the eye, with keratitis and
acute retinal necrosis, occurs infrequently. Proctitis may occur secondary to anal intercourse. HSV infection
(primarily HSV-1) is the most common cause of nonepidemic viral encephalitis. Aseptic (sometimes recurrent)
meningitis, sacral radiculopathy, and transverse myelitis may also occur after HSV-2 genital infection. Infection
of visceral organs, including the esophagus, lung, and liver, may result from viremia or direct extension from
nearby mucosal surfaces. The common association of erythema multiforme and HSV infection is a
consequence of the host's immune response to the virus.
Slide7Management:
The nucleoside analogues acyclovir,
valacyclovir
, and
famciclovir
are effective for treating episodic HSV-1
and HSV-2 infections and suppressing recurrent infections. Topical antiviral agents have limited usefulness
for treating mucocutaneous disease; however, they are recommended for treatment of HSV eye infections.
Intravenous acyclovir is required to treat HSV encephalitis. No studies of efficacy of systemic antiviral
therapy for HSV aseptic meningitis exist.
Slide8SEVERE MUCOCUTANEOUS HERPES SIMPLEX IN RENAL TRANSPLANT RECEPIENT
Slide9PRIMARY
HERPES SIMPLEX JINJIVOSTOMATITIS IN A CHILD